H E Broxmeyer

1.2k total citations
15 papers, 817 citations indexed

About

H E Broxmeyer is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, H E Broxmeyer has authored 15 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Oncology and 5 papers in Hematology. Recurrent topics in H E Broxmeyer's work include Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). H E Broxmeyer is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). H E Broxmeyer collaborates with scholars based in United States, France and Canada. H E Broxmeyer's co-authors include Stephanie Cooper, Giao Hangoc, Károly Nikolics, Anthony J. Mason, Ralph Schwall, Li Lu, K H Fife, Robert Hromas, Chang H. Kim and Mitchell D. Krathwohl and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

H E Broxmeyer

15 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H E Broxmeyer United States 14 392 346 278 174 123 15 817
James Ihle United States 14 544 1.4× 310 0.9× 347 1.2× 185 1.1× 146 1.2× 18 1.0k
J R Keller United States 15 561 1.4× 296 0.9× 484 1.7× 329 1.9× 105 0.9× 19 1.2k
Tomoaki Kuwaki Japan 11 417 1.1× 246 0.7× 359 1.3× 309 1.8× 103 0.8× 18 977
GC Baldwin United States 11 443 1.1× 255 0.7× 166 0.6× 138 0.8× 115 0.9× 16 803
Cathy Quilici Australia 16 698 1.8× 239 0.7× 259 0.9× 141 0.8× 90 0.7× 18 1.1k
Fleur François United States 8 571 1.5× 281 0.8× 214 0.8× 82 0.5× 195 1.6× 9 911
J A Johnston United States 6 626 1.6× 446 1.3× 232 0.8× 94 0.5× 60 0.5× 8 979
AR Dunn Australia 5 610 1.6× 255 0.7× 173 0.6× 148 0.9× 196 1.6× 7 952
Uri Nir Israel 10 404 1.0× 181 0.5× 358 1.3× 65 0.4× 159 1.3× 13 826
M B Widmer United States 11 699 1.8× 313 0.9× 295 1.1× 108 0.6× 91 0.7× 18 1.2k

Countries citing papers authored by H E Broxmeyer

Since Specialization
Citations

This map shows the geographic impact of H E Broxmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H E Broxmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H E Broxmeyer more than expected).

Fields of papers citing papers by H E Broxmeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H E Broxmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H E Broxmeyer. The network helps show where H E Broxmeyer may publish in the future.

Co-authorship network of co-authors of H E Broxmeyer

This figure shows the co-authorship network connecting the top 25 collaborators of H E Broxmeyer. A scholar is included among the top collaborators of H E Broxmeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H E Broxmeyer. H E Broxmeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Christopherson, Kent W., Scott Cooper, Giao Hangoc, & H E Broxmeyer. (2003). CD26 is essential for normal G-CSF–induced progenitor cell mobilization as determined by CD26−/− mice. Experimental Hematology. 31(11). 1126–1134. 61 indexed citations
2.
Braun, Stephen E., Bruce R. Blazar, Paul J. Orchard, et al.. (1999). Flt3 Ligand Antitumor Activity in a Murine Breast Cancer Model: A Comparison with Granulocyte-Macrophage Colony-Stimulating Factor and a Potential Mechanism of Action. Human Gene Therapy. 10(13). 2141–2151. 35 indexed citations
3.
Hromas, Robert, Chang H. Kim, M Klemsz, et al.. (1997). Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. The Journal of Immunology. 159(6). 2554–2558. 125 indexed citations
4.
Broxmeyer, H E. (1996). Is interleukin 17, an inducible cytokine that stimulates production of other cytokines, merely a redundant player in a sea of other biomolecules?. The Journal of Experimental Medicine. 183(6). 2411–2415. 57 indexed citations
5.
Sarris, Andreas H., Danai Daliani, Mary K. Crow, et al.. (1996). Interferon-Inducible Protein-10 and the Pathogenesis of Cutaneous T-Cell Lymphomas. Leukemia & lymphoma. 24(1-2). 103–110. 9 indexed citations
6.
Youn, Byung‐Soo, H E Broxmeyer, Stephanie Cooper, et al.. (1995). A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors. The Journal of Immunology. 155(5). 2661–2667. 57 indexed citations
7.
Zhou, Shang Zhen, Stephanie Cooper, Lei Kang, et al.. (1994). Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood.. The Journal of Experimental Medicine. 179(6). 1867–1875. 96 indexed citations
8.
Pelus, Louis M., et al.. (1994). In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.. PubMed. 22(3). 239–47. 16 indexed citations
9.
Sarris, A H, H E Broxmeyer, Urs Wirthmueller, et al.. (1993). Human interferon-inducible protein 10: expression and purification of recombinant protein demonstrate inhibition of early human hematopoietic progenitors.. The Journal of Experimental Medicine. 178(3). 1127–1132. 87 indexed citations
10.
Broxmeyer, H E, Margaret Masterson, Cynthia DeLaat, et al.. (1993). Haemopoietic stem/progenitor cell transplant in Fanconi anaemia using HLA‐matched sibling umbilical cord blood cells. British Journal of Haematology. 85(2). 419–422. 48 indexed citations
11.
Hangoc, Giao, DE Williams, JH Falkenburg, & H E Broxmeyer. (1989). Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors.. The Journal of Immunology. 142(12). 4329–4334. 18 indexed citations
12.
Broxmeyer, H E, Douglas E. Williams, Scott Cooper, Giao Hangoc, & Peter Ralph. (1988). Recombinant human granulocyte‐colony stimulating factor and recombinant human macrophage colony stimulating factor synergize in vivo to enhance proliferation of granulocyte‐macrophage, erythroid, and multipotential progenitor cells in mice. Journal of Cellular Biochemistry. 38(2). 127–136. 19 indexed citations
13.
Broxmeyer, H E, Li Lu, Stephanie Cooper, et al.. (1988). Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin.. Proceedings of the National Academy of Sciences. 85(23). 9052–9056. 126 indexed citations
14.
Williams, DE, Sandra K. Cooper, & H E Broxmeyer. (1988). Effects of hematopoietic suppressor molecules on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells.. PubMed. 48(6). 1548–50. 23 indexed citations
15.
Broxmeyer, H E, et al.. (1978). Communication between white cells and the abnormalities of this in leukemia. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 516(2). 129–166. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026